Posts

BeOne boosts US footprint with $300M New Jersey expansion

on

Ipsen signals more deals to continue buying spree

on

Ionis scores transformational FDA label expansion for Tryngolza

on

Regeneron doubles down on CytomX despite other pharma exits, expanding pact to up to ~$4 billion potential value

on

SKIA HEAD Gains FDA Clearance for AR Surgical Guidance

on

With Voxzogo under pressure, BioMarin touts trial win in label expansion bid

on

CSL Takes $5B Impairment Charge and Revenue Cut

on

Argenx's Vyvgart and Vyvgart Hytrulo Receive FDA Label Expansion for All Adult gMG Patients

on

Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth

on

QuantHealth Bolsters Executive Leadership Team to Support Expanding Product Portfolio and Growing Client Footprint

on

Insmed's Arikayce Achieves Phase 3 Success in MAC Lung Disease, Paving Way for Label Expansion and Potential Blockbuster Status

on

CytomX Announces Positive Phase 1 Data for Varsetatug Masetecan in Late-Line Colorectal Cancer

on

Novartis Expands Radioligand Therapy Manufacturing with New German Facility

on

Hims & Hers Acquires Australian Digital Health Company Eucalyptus for Up to $1.15 Billion

on

Novo Nordisk Plans Expansion of Irish Facility in Athlone for Wegovy Pill Production

on

Sevaro Health Expands Leadership Team with Key Appointments

on

Hua Medicine Advances Dorzagliatin Expansion Beyond China with Hong Kong NDA Acceptance

on

Hua Medicine Advances Dorzagliatin Expansion Beyond China with Hong Kong NDA Acceptance

on

No Recent News on BetterHelp's Quiet AI Expansion

on

FDA broadens label for Amgen’s Uplizna as it enters rare disease competition

on